Company · ENTG
Entegris, Inc.
Name as listed on its exchange; filed with the SEC as ENTEGRIS INC.
Nasdaq's symbol directory lists ENTG on Nasdaq as “Entegris, Inc. - Common Stock”.
In the 12 months to Nov 19, 2026: insiders sold on 3 occasions ($1.3M); 1 filing by holders of 5% or more; 16 congressional trade disclosures; 3 company reports (Form 8-K, since May 26, 2026).
All insider filings at the SEC · Appeared in No. 14
Insider trades · SEC Form 4
Those inside the hall
Open-market purchases and sales only. Legs one person filed for one day are combined.
Who traded
- Colella Joseph, SVP and General Counsel sold $644K
- Blachier Olivier, President, Materials Solutions sold $321K
- Rice Susan G., SVP, Global Human Resources sold $308K
Every trade (3)
- SELLBlachier Olivier, President, Materials Solutions sold $321K
- SELLColella Joseph, SVP and General Counsel sold $644K
- SELLRice Susan G., SVP, Global Human Resources sold $308K
Large holders · SEC Schedules 13D and 13G
Five percent and over
Anyone who comes to hold more than 5% of a company's voting shares must tell the SEC. A Schedule 13D is filed by a holder who may seek to influence the company; a 13G by one who states it is a passive investor. An amendment updates an earlier filing, and a stake reported as 0% means the holder says it has sold all, or nearly all, of its shares. Every recent 13D and 13G
- Vanguard Portfolio Management 4.98%
Congress · STOCK Act
The Althing
Periodic transaction reports. Amounts are the ranges members report; the trade date is when it happened, the report can come up to 45 days later.
- April McClain Delaney (D-MD06): Sale $100,001 - $250,000
- April McClain Delaney (D-MD06): Purchase $1,001 - $15,000
- April McClain Delaney (D-MD06): Purchase $1,001 - $15,000
- April McClain Delaney (D-MD06): Purchase $1,001 - $15,000
- April McClain Delaney (D-MD06): Purchase $1,001 - $15,000
- Michael T. McCaul (R-TX10): Purchase $1,001 - $15,000
- Michael T. McCaul (R-TX10): Purchase $1,001 - $15,000
- April McClain Delaney (D-MD06): Purchase $1,001 - $15,000
- April McClain Delaney (D-MD06): Purchase $1,001 - $15,000
- April McClain Delaney (D-MD06): Purchase $1,001 - $15,000
- April McClain Delaney (D-MD06): Purchase $1,001 - $15,000
- April McClain Delaney (D-MD06): Purchase $1,001 - $15,000
- April McClain Delaney (D-MD06): Sale $1,001 - $15,000
- Michael T. McCaul (R-TX10): Purchase $1,001 - $15,000
- April McClain Delaney (D-MD06): Sale $1,001 - $15,000
- Michael T. McCaul (R-TX10): Purchase $1,001 - $15,000
Executive branch · OGE Form 278-T
Reported by the President
3 confirmed trades on scanned reports whose security name matches this company's own filed name exactly (letter case, punctuation and Inc/Corp-style endings aside). All of Donald J. Trump's reports
- Purchase: ENTEGRIS INC $1,001 – $15,000
- Purchase: ENTEGRIS INC $1,001 – $15,000
- Purchase: ENTEGRIS INC $1,001 – $15,000
Company reports · SEC Form 8-K
In its own words
Current reports the company filed with the SEC; most items are due within four business days of the event. Each line lists the report's items by the SEC's own titles; the filing says what happened. Reports collected since May 26, 2026; every 8-K at the SEC.
- Regulation FD disclosure; Other events Nov 10, 2026
- Results of operations and financial condition Oct 29, 2026
- Other events Oct 14, 2026
Lobbying · Senate LDA reports
Lobbying filed
2 quarterly lobbying reports for 2026 naming Entegris, Inc. as the client: 2 by outside firms it hired. Each line is one report as filed; an amended report is a line of its own. An outside firm states what the company paid it; the company's own report states its whole lobbying spend, which can include those fees, so the lines are not added up. Reports are collected in batches and a quarter can be missing here; the full record is at lda.gov.
- HOLLAND & KNIGHT LLP $80K
- HOLLAND & KNIGHT LLP $80K
Sources: SEC EDGAR (Forms 4, 144 and 8-K), Senate LDA lobbying reports, OGE Form 278-T reports on whitehouse.gov and STOCK Act periodic transaction reports. Filings can be late, amended or wrong at the source; see methodology.